Spruce Biosciences, Inc. Shareholders' Equity
Spruce Biosciences, Inc. (SPRB) had Shareholders' Equity of $83.73 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $83.73M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $34.65M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $42.52M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $5.39M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $83.73M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $34.65M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $42.52M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $5.39M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $13.18M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $15.32M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $28.82M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $51.64M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $59.17M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $66.62M 10-Q · filed 2025-08-14 |
| 2023-12-31 | $76.51M 10-K · filed 2026-03-09 |
| 2023-09-30 | $85.38M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $96.56M 10-Q · filed 2024-11-12 |
| 2023-03-31 | $108.00M 10-Q · filed 2024-08-12 |
| 2022-12-31 | $68.49M 10-K · filed 2025-04-15 |
| 2022-09-30 | $78.47M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $89.12M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $100.24M 10-Q · filed 2023-08-14 |
| 2021-12-31 | $111.37M 10-K · filed 2024-03-18 |
| 2021-09-30 | $119.72M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $130.11M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $140.72M 10-Q · filed 2022-08-10 |
| 2020-12-31 | $149.43M 10-K · filed 2023-03-16 |
| 2020-09-30 | -$51.44M 10-Q · filed 2021-11-15 |
| 2020-06-30 | -$42.12M 10-Q · filed 2021-11-15 |
| 2020-03-31 | -$35.77M 10-Q · filed 2021-05-12 |
| 2019-12-31 | -$30.64M 10-K · filed 2022-03-14 |
| 2019-09-30 | -$27.52M 10-Q · filed 2020-11-18 |
| 2019-06-30 | -$25.07M 10-Q · filed 2020-11-18 |
| 2019-03-31 | -$21.91M 10-Q · filed 2020-11-18 |
| 2018-12-31 | -$17.80M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |